Table 4

Treatment-emergent adverse events. Only those events reported in ≥5% of subjects in either group are included.

Adverse eventSTX209, n (%)Placebo, n (%)
Upper respiratory tract infection8 (13)6 (10)
Headache5 (8)1 (2)
Sedation5 (8)1 (2)
Fatigue4 (6)1 (2)
Irritability4 (6)4 (6)
Diarrhea3 (5)5 (8)
Increased appetite4 (6)2 (3)
Vomiting4 (6)1 (2)
Aggression3 (5)4 (6)
Nasopharyngitis2 (3)6 (10)